RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...

RBC Capital raised the firm’s price target on CyberArk (CYBR) to $481 from $410 and keeps an Outperform rating on the shares. The company posted a strong quarter with all metrics and initial 2025 ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Dexcom (DXCM – Research Report), with a price ...

In a report released today, Robert Kwan from RBC Capital maintained a Buy rating on Brookfield Corporation (BN – Research Report), with a price ...

European miners are scheduled to report fourth-quarter and full-year results over the next four weeks. Gold prices are trading near record highs as investors turn to safe haven assets as economic and ...

State of Alaska Department of Revenue lifted its position in RBC Bearings Incorporated (NYSE:RBC – Free Report) by 5.8% in ...

RBC Capital Markets adjusted its price target for Q2 Holdings stock, raising it to $108 from the previous $105, while maintaining a Sector Perform rating. The increase follows Q2 Holdings' report of ...

Following a record year for catastrophe bond issuance in 2024, the cat bond market remains strong, and according to analysts ...

Brighthouse posted very strong Q4 earnings of $5.88 per share, beating the Zacks Consensus Estimate of $4.44 per share.